HLA-C and acute leukemia: Results from our series of pediatric acute leukemia show a clear association between relapse and the presence of the KIR2DL1/HLA-C*04 interaction, present in 17.6% of patients with relapse and only in 4.4% of patients without relapse, which highlights the possible participation of immune mechanisms in this process.